Cargando…

Should biologics for psoriasis be interrupted in the era of COVID-19?

Detalles Bibliográficos
Autores principales:	Lebwohl, Mark, Rivera-Oyola, Ryan, Murrell, Dedee F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the American Academy of Dermatology, Inc. 2020
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156810/ https://www.ncbi.nlm.nih.gov/pubmed/32199889 http://dx.doi.org/10.1016/j.jaad.2020.03.031

Ejemplares similares

Reply to: “Biologics for psoriasis during COVID-19 outbreak”
por: Murrell, Dedee F., et al.
Publicado: (2020)

Reply to: “COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution”
por: Lebwohl, Mark, et al.
Publicado: (2020)

Secukinumab lowers expression of ACE2 in affected skin of patients with psoriasis
por: Krueger, James G., et al.
Publicado: (2021)

Reply to research letter
por: Rivera-Oyola, Ryan, et al.
Publicado: (2020)

Psoriasis and osteoporosis: a literature review
por: Wi, Dohyen, et al.
Publicado: (2022)

Use of a hybrid teledermatology model in an Australian tertiary hospital during the COVID-19 pandemic
por: Cowan, Timothy L., et al.
Publicado: (2022)

Eczematous reactions to psoriasis biologics treated with dupilumab: A case series
por: Koschitzky, Merav, et al.
Publicado: (2021)

Dermatologic findings in 2 patients with COVID-19
por: Rivera-Oyola, Ryan, et al.
Publicado: (2020)

New onset and exacerbation of psoriasis after COVID-19 vaccination
por: Wei, Nancy, et al.
Publicado: (2021)

The role of women as past and present advocates for vaccinations: Relevance in the COVID-19 setting
por: Daniel, Benjamin S., et al.
Publicado: (2020)

Long-term follow-up of epidermolysis bullosa in real practice shows stability of the Epidermolysis Bullosa Disease Activity and Scarring Index and improvement with some off-label therapies
por: Ho, Genevieve, et al.
Publicado: (2022)

Embracing diversity in dermatology: Creation of a culture of inclusion in dermatologic publishing
por: Murase, Jenny E., et al.
Publicado: (2021)

The International Reach of the International Journal of Women's Dermatology and the Women's Dermatologic Society
por: Murrell, Dedee F., et al.
Publicado: (2021)

Heralding change within dermatology: Response of the International Journal of Women’s Dermatology (IJWD) to the twin pandemic of racism
por: Murase, Jenny E., et al.
Publicado: (2021)

COVID, Biologics, and Psoriasis Therapy
por: Elston, Dirk M.
Publicado: (2020)

Mental health, insomnia and suicidal ideation during treatment with apremilast
por: Cowan, Timothy L., et al.
Publicado: (2022)

Pemphigoid gestationis and preeclampsia in a donor-egg IVF pregnancy
por: Cowan, Timothy L., et al.
Publicado: (2022)

The response of the Women’s Dermatologic Society and the International Journal of Women’s Dermatology to the COVID-19 pandemic
por: Murase, Jenny E., et al.
Publicado: (2020)

The Potential Protective Effect of Estrogen: A Plausible Theory for why COVID-19 Mortality is Lower in Females
por: Murrell, Dedee F., et al.
Publicado: (2020)

Psoriasis: Overview and Diagnosis
por: Kimmel, Grace W., et al.
Publicado: (2018)

Secukinumab treatment showed improved quality of life in patients with chronic plaque psoriasis in Australia: Results from the HOPE study
por: Foley, Peter, et al.
Publicado: (2022)

Use of biologics in the era of COVID-19: Where do we stand?
por: Lee, Young Bin, et al.
Publicado: (2020)

Conducting dermatology clinical trials during the COVID-19 pandemic
por: Sheriff, Tabrez, et al.
Publicado: (2021)

Shedding light on the impact of hidradenitis suppurativa on women and their families: A focus of the International Journal of Women's Dermatology
por: Revankar, Rishab, et al.
Publicado: (2021)

Impact of the COVID-19 Pandemic on Radiotherapy Interruptions and Patient Outcomes
por: Hsu, C.X., et al.
Publicado: (2023)

Autoimmune blistering skin diseases triggered by COVID-19 vaccinations: An Australian case series
por: Cowan, Timothy L., et al.
Publicado: (2023)

Treatment considerations for patients with pemphigus during the COVID-19 pandemic
por: Shakshouk, Hadir, et al.
Publicado: (2020)

Evaluation of skin of color content in Skin Research and Technology
por: Sun, Mary, et al.
Publicado: (2022)

COVID-19 and biologics for psoriasis: A high-epidemic area experience—Bergamo, Lombardy, Italy
por: Carugno, Andrea, et al.
Publicado: (2020)

Balneotherapy in the era of COVID-19: should it be recommended or not?
por: Guvener, Orhan
Publicado: (2020)

Considerations for the use of immunosuppression for the management of pemphigus during the COVID-19 pandemic with a focus on rituximab: Case reports from a single center experience in Australia
por: Koszegi, Ben, et al.
Publicado: (2023)

Authors' reply to the comment “Treatment considerations for patients with pemphigus during the COVID-19 pandemic”
por: Shakshouk, Hadir, et al.
Publicado: (2021)

Normocomplementaemic urticarial vasculitis: effective treatment with omalizumab
por: de Brito, Marianne, et al.
Publicado: (2018)

Maternity leave: how to make it fairer for all
por: Murrell, Dédée F.
Publicado: (2015)

A lesson learned about predatory journals and their difference from peer-reviewed open-access publishing
por: Murrell, Dedee F.
Publicado: (2016)

Off-Label Biologic Regimens in Psoriasis: A Systematic Review of Efficacy and Safety of Dose Escalation, Reduction, and Interrupted Biologic Therapy
por: Brezinski, Elizabeth A., et al.
Publicado: (2012)

Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis
por: Wu, J.J., et al.
Publicado: (2022)

Paradoxical improvement of life quality in the COVID-19 era in psoriasis patients
por: Boch, Katharina, et al.
Publicado: (2022)

Editorial: Challenges of COVID-19 in dermatology patients on immunosuppression: Risk, outcome, vaccination, and beyond
por: Mahmoudi, Hamidreza, et al.
Publicado: (2022)

Failures with COVID‐19 at the international level must not be repeated in an era facing global catastrophic biological risks
por: Boyd, Matt, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qrmqk9alosv7pdr2dmgq57sgog